Refine
Year of publication
Document Type
- Article (412)
- Preprint (219)
- Contribution to a Periodical (8)
- Conference Proceeding (6)
- Working Paper (6)
- Book (1)
- Report (1)
Has Fulltext
- yes (653)
Is part of the Bibliography
- no (653)
Keywords
- e +-e − Experiments (12)
- BESIII (11)
- Branching fraction (8)
- Particle and Resonance Production (6)
- Charm Physics (5)
- Spectroscopy (5)
- Heavy-ion collisions (4)
- Lepton colliders (4)
- Quarkonium (4)
- portal hypertension (4)
- stochastic differential utility (4)
- COVID-19 (3)
- Charmed mesons (3)
- Diffraction (3)
- Elastic scattering (3)
- Electroweak interaction (3)
- Exotics (3)
- Hadronic decays (3)
- Polarization (3)
- e+-e− Experiments (3)
- Beam Energy Scan (2)
- Biomarkers (2)
- Branching fractions (2)
- Brassica napus (2)
- COVID-19 surveillance (2)
- Cancer (2)
- Charm physics (2)
- Charmonium (2)
- Chiral Magnetic Effect (2)
- Collectivity (2)
- Correlation (2)
- Electroweak Interaction (2)
- Epidemiology (2)
- FBSDE (2)
- Flavour Physics (2)
- Immunology (2)
- Leptonic, semileptonic & radiative decays (2)
- Mechanisms of disease (2)
- Mitochondria (2)
- Non-small cell lung cancer (2)
- Omicron (2)
- Particle decays (2)
- RHIC (2)
- Radiative decay (2)
- Radiotherapy (2)
- Rare diseases (2)
- Registries (2)
- SARS-CoV-2 (2)
- SARS-CoV-2 monitoring (2)
- STAR (2)
- Shear viscosity (2)
- Treatment (2)
- asset pricing (2)
- cirrhosis (2)
- consumption-portfolio choice (2)
- incomplete markets (2)
- microdosing (2)
- recursive utility (2)
- 140Ce (1)
- 3years (1)
- ACLF (1)
- ADGRE1 (1)
- AIS (1)
- ALK (1)
- ALK-rearranged NSCLC (1)
- ARDS (1)
- ATM (1)
- Acuris (1)
- Acute elbow dislocation (1)
- Advanced biliary tract cancer (1)
- Alpha-synuclein (1)
- Alternative oxidase (1)
- Antibiotic therapy (1)
- Antirheumatic agents (1)
- Araneae (1)
- Artificial Intelligence (1)
- Augenerkrankungen (1)
- Autosomal recessive cutis laxa type 1C (1)
- B-slope (1)
- B.1.1.529 (1)
- BA.4 (1)
- BA.5 (1)
- BESIII detector (1)
- BI1361849 (1)
- BTC (1)
- Bacterial leakage (1)
- Beam energy scan (1)
- Bhabha (1)
- Biodiversity Data (1)
- Biogeography (1)
- Biomedical engineering (1)
- Biomonitoring (1)
- Bipolar disorder (1)
- Born cross section (1)
- Born cross section measurement (1)
- Botanical Collections (1)
- Branching fraction measurement (1)
- CAD/CAM crown (1)
- CAKUT (1)
- CBA (1)
- CEP68 (1)
- COMP (1)
- COVID 19 (1)
- CP violation (1)
- CRVO (1)
- CV9202 (1)
- Cardiac implantable electronic devices (1)
- Cardiac rehabilitation (1)
- Cardiac resynchronization therapy (1)
- Cardiovascular disease risk (1)
- Cardiovascular diseases (1)
- Cement gap (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Charm vector (1)
- Charmonia (1)
- Charmonium (-like) (1)
- Chest pain unit (1)
- Child (1)
- Chiral magnetic effect (1)
- Circadian (1)
- Cirrhosis (1)
- Classification (1)
- Clinical trial (1)
- Coalescence (1)
- Cognitive impairment (1)
- Cohort studies (1)
- Cold nuclear matter effects (1)
- Colorectal cancer (1)
- Comparative effectiveness research (1)
- Complex II (1)
- Concept paper (1)
- Conometric connection (1)
- Consensus (1)
- Consensus document (1)
- Conservation (1)
- Consumption hump (1)
- Coronary intervention (1)
- Critical care (1)
- Critical point (1)
- Cross section (1)
- D meson (1)
- DME (1)
- DNA-PK (1)
- Dark photon (1)
- Dark sector (1)
- Data Standard (1)
- Data protection (1)
- Data sharing (1)
- Datenschutz (1)
- Dermatomyositis (1)
- Detection workflow (1)
- Deuteron production (1)
- Deutschland (1)
- Di-hadron correlations (1)
- Diagnosis (1)
- Digital (1)
- Digitization (1)
- ECM (1)
- EMR1 (1)
- Ecology (1)
- Ecophysiology (1)
- Ectoparasites (1)
- Education (1)
- Effective form factor (1)
- Einwanderer (1)
- Elastogenesis (1)
- Electromagnetic form factor (1)
- Electromagnetic form factors (1)
- Electromagnetic transitions (1)
- Elliptic flow (1)
- Equity (1)
- Etanercept (1)
- Exercise training (1)
- Experimental nuclear physics (1)
- Experimental particle physics (1)
- Extracellular matrix (1)
- Eye diseases (1)
- EyesiNet (1)
- F4/80 (1)
- FOS: Physical sciences (1)
- Fibulin-4 (1)
- Fibulin-5 (1)
- Flavor changing neutral currents (1)
- Flavor symmetries (1)
- Flow (1)
- Form factors (1)
- Forward physics (1)
- Fracture type (1)
- Fremdbild (1)
- GLM (1)
- Genetics (1)
- Genetics research (1)
- Geschichte 1981-1997 (1)
- Gomphus flavipes (1)
- Groomed jet radius (1)
- HCC (1)
- Hadron-Hadron scattering (experiments) (1)
- Hadronization (1)
- Hand-foot syndrome (1)
- Hantavirus (1)
- Health information (1)
- Health-seeking behaviour (1)
- Heart failure (1)
- Heavy Ion Experiments (1)
- Heavy Quark Production (1)
- Heavy ion collisions (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-ion (1)
- Helicity amplitude analysis (1)
- Helpline (1)
- Herbaria (1)
- Hif1α (1)
- High Energy Physics - Experiment (hep-ex) (1)
- Higher moments (1)
- Hyperons (1)
- Hypertension (1)
- Hypofractionated radiotherapy (1)
- ICU (1)
- IHMCIF (1)
- IL-6 (1)
- ILUVIEN (1)
- IR (1)
- ISS (1)
- Immunogenetics (1)
- Immunomonitoring (1)
- Implantable cardioverter-defibrillator (1)
- Inclusive branching fraction (1)
- Inflammation (1)
- Initial state radiation (1)
- Integrative Modeling (1)
- Interference fragmentation function (1)
- Invisible decays (1)
- J/ψ suppression (1)
- Jet substructure (1)
- K0S (1)
- K3EDTA plasma sampling (1)
- K48-linked (1)
- K63-linked (1)
- Konzeptpapier (1)
- Landscape ecology (1)
- Landschaftsökologie (1)
- Latent transforming growth factor β-binding protein 4 (1)
- Lehre (1)
- Libellen (1)
- Lifestyle (1)
- Lipidomics (1)
- Liver diseases (1)
- Ltbp-4 (1)
- Ltbp-4L (1)
- Ltbp-4S (1)
- L´evy framework (1)
- MACS (1)
- MCP-1 (1)
- MMPs (1)
- MRSA (1)
- MYCN amplification (1)
- Marginal integrity (1)
- Metabolomics (1)
- Microgap (1)
- Mitochondrial disease (1)
- Models & methods for nuclear reactions (1)
- Molecular diagnostic testing (1)
- Molecular medicine (1)
- Multiple parton interactions (1)
- Multivariate analysis (1)
- Myotis myotis (1)
- NAFLD (1)
- NET (1)
- NMDA IgA/IgM antibodies (1)
- NMDA antibody (1)
- NMR spectroscopy (1)
- NSCLC (1)
- NSTEMI (1)
- Net-charge correlations (1)
- Net-charge fluctuations (1)
- Netzhaut (1)
- Neutrinos (1)
- Neutron physics (1)
- Nonflow (1)
- Nuclear reactions (1)
- Nutzen (1)
- Oncogenes (1)
- Open Access (1)
- Ophiogomphus cecilia (1)
- Orphan disease (1)
- Osteoporosis (1)
- Outcome (1)
- Oxidative phosphorylation (1)
- PBSC (1)
- PDB-Dev (1)
- PDBx/mmCIF (1)
- PDE‐5‐inhibitor (1)
- PDGFRβ (1)
- PI3K (1)
- PRRT (1)
- PTEN (1)
- Pacemaker (1)
- Parkinson disease (1)
- Parkinson’s disease (1)
- Particle and resonance production (1)
- Particle phenomena (1)
- Patient safety (1)
- Periodontal disease (1)
- Periodontal therapy (1)
- Pest-crop interactions (1)
- Phalangeal fractures (1)
- Physical activity (1)
- Plasminogen (1)
- Platelets (1)
- Pneumonia (1)
- Portal veins (1)
- Poverty (1)
- Pre-analytics (1)
- Preclinical research (1)
- Predictive markers (1)
- Prevention (1)
- Prognosis (1)
- Prognostic models (1)
- Prostaglandin (1)
- Proton (1)
- Proton-proton collisions (1)
- Proton–proton collisions (1)
- Psychiatric disorders (1)
- Psychiatry (1)
- Puumala virus (1)
- QCD (1)
- Quantum chromodynamics (1)
- RAS pathway (1)
- RNA (1)
- RNA-binding proteins (1)
- Radiative capture (1)
- Rapps (1)
- Rare decays (1)
- Real world (1)
- Register (1)
- Remission (1)
- Research Infrastructure (1)
- Resonance reactions (1)
- Respiratory chain (1)
- Retina (1)
- Retro-IDEAL (1)
- Rh(II) catalysis (1)
- Rheumatoid arthritis (1)
- Rodent-associated infections (1)
- Roosting place (1)
- SARS CoV 2 (1)
- SD-OCT (1)
- SLC20A1 (1)
- SPSS (1)
- STED superresolution (1)
- Sampling protocol (1)
- Schulbuch (1)
- Schädling (1)
- Seasonal variation (1)
- Seltene Erkrankungen (1)
- Semantics (1)
- Semi-leptonic decays (1)
- Single-molecule biophysics (1)
- Social determinants (1)
- SoftDrop (1)
- Solar insolation (1)
- Sorafenib (1)
- Spatial scales (1)
- Spatio-temporal patterns (1)
- Spin alignment (1)
- Spine care (1)
- Spinturnix myoti (1)
- Splitting function (1)
- Standardization (1)
- Staphylococcus aureus (1)
- Stentoplasty (1)
- Steroid (1)
- Student (1)
- Suicide (1)
- Sunlight (1)
- Super-resolution microscopy (1)
- Surgical oncology (1)
- TACE (1)
- TGR(mREN2)27 (1)
- TP53 mutation status (1)
- Taxonomy (1)
- Techniques Electromagnetic calorimeters (1)
- Telemedicine (1)
- Thermal model (1)
- Thoracic trauma (1)
- Threshold effect (1)
- Thrombosis (1)
- Thromboxane (1)
- Transversity (1)
- UWB diagnostics (1)
- VEGF (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- Variant of concern (1)
- Veins (1)
- Vertebral augmentation (1)
- Vertebral body stenting (1)
- Vertebral fracture (1)
- Vitreous samples (1)
- Wastewater-based epidemiology (WBE) (1)
- Western diet (1)
- Worldwide Protein Data Bank (1)
- X-ray crystallography (1)
- Y states (1)
- accessory proteins (1)
- acute decompensation (1)
- acute myeloid leukemia (1)
- acute-on-chronic liver failure (1)
- adaptive cardiac remodelling (1)
- adverse events (1)
- alternative oxidase (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- autoantibodies (1)
- azaindole (1)
- backward stochastic differential equation (1)
- bioactivity testing (1)
- bladder exstrophy-epispadias complex (1)
- bleomycin (1)
- bundle (1)
- c-kit (1)
- capture (1)
- cardiac ischaemia‐reperfusion (1)
- cartilage (1)
- cell stress (1)
- cell-free protein synthesis (1)
- center-of-mass energy (1)
- centrosome (1)
- centrosome linker (1)
- cerium (1)
- certainty equivalents (1)
- charmonium-like states (1)
- cloacal malformation (1)
- complications (1)
- computed tomography (1)
- consumption hump (1)
- convergence (1)
- cross-section (1)
- cytarabine dose (1)
- diabetic macular edema (1)
- diazo compounds (1)
- dimuon (1)
- dynamic programming (1)
- e+e − annihilation (1)
- e+e⁻ − Experiments (1)
- e+e− Experiments (1)
- easyPACId (1)
- ectosomes (1)
- education (1)
- elderly (1)
- electron transport chain (1)
- electron-positron collision (1)
- epigeic spiders (1)
- epigäische Spinnen (1)
- erectile dysfunction (1)
- exosomes (1)
- extracellular vesicles (1)
- fibrogenesis (1)
- fixed point approach (1)
- fluocinolone acetonide (1)
- fluorescent dye (1)
- functional genetics (1)
- generalist predators (1)
- generalistische Prädatoren (1)
- geriatric medicine (1)
- global change (1)
- guidelines (1)
- habit formation (1)
- habitat destruction (1)
- hadron spectroscopy (1)
- hadronic events (1)
- health information exchange (1)
- heavy-ion collisions (1)
- helicity amplitude analysis (1)
- hematotoxicity (1)
- hepatic encephalopathy (1)
- hepatic stellate cells (1)
- hepatocellular cancer (1)
- high-risk neuroblastoma (1)
- immunity (1)
- impatience (1)
- in vitro models (1)
- inclusive J/ψ decays (1)
- inflammation (1)
- intrinsically disordered region (1)
- jumps (1)
- kidney formation (1)
- land use (1)
- leisure (1)
- life-cycle utility maximization (1)
- liver (1)
- liver fibrosis (1)
- mRNA active cancer immunotherapy (1)
- macrophage (1)
- metallo β lactamases (1)
- microparticles (1)
- microvesicles (1)
- microwave ablation (1)
- microwave breast imaging (1)
- minimal information requirements (1)
- mouse (1)
- mouse model (1)
- multiresistant bacteria (1)
- n_TOF (1)
- natural products (1)
- nematophin (1)
- neuroendocrine tumor (1)
- neutralizing antibodies (1)
- neutron (1)
- nonstructural proteins (1)
- non‐selective beta‐blocker (1)
- normalization (1)
- nucleosynthesis (1)
- number of J/ψ events (1)
- optimal investment (1)
- osteoarthritis (1)
- oval split ring resonator (1)
- p+p collisions (1)
- p53 pathway (1)
- patient study (1)
- peptide receptor radionuclide therapy (1)
- peripheral blood stem cell collection (1)
- polyubiquitin (1)
- portosystemic shunt (1)
- prevention (1)
- primary biliary cholangitis (1)
- proteobacteria (1)
- qualitative research (1)
- quality control (1)
- rare diseases (1)
- reactive oxygen species (1)
- renin-angiotensin system (1)
- reproducibility (1)
- resectability (1)
- rigor (1)
- rootletin (1)
- s-process (1)
- second line therapy (1)
- sequential ALK-inhibitor therapy (1)
- simplified production (1)
- sorafenib (1)
- sphingolipid sphingosine-1-phosphate (1)
- sphingolipids (1)
- sphingosine-1-phosphate receptor 5 (1)
- spike protein (1)
- spontaneous portosystemic shunt (1)
- standardization (1)
- steatosis (1)
- stochastic volatility (1)
- structural proteins (1)
- surgery (1)
- systemic sclerosis (1)
- tetraquark (1)
- theranostics (1)
- thiol inhibitors (1)
- thrombospondins (1)
- treatment (1)
- treatment response (1)
- trigger efficiency (1)
- ubiquitin-conjugating enzymes (1)
- urinary tract development (1)
- ursodeoxycholic acid (1)
- variant of concern (1)
- variants of concern (1)
- wage hump (1)
- wastewater-based epidemiology (WBE) (1)
- welfare loss (1)
- wwPDB (1)
- zebrafish development (1)
- Λ+c baryon (1)
- Σ hyperon (1)
- Υ suppression (1)
- ψ(3686) (1)
- fibrogenesis (1)
Institute
- Physik (383)
- Frankfurt Institute for Advanced Studies (FIAS) (106)
- Medizin (91)
- Geowissenschaften (23)
- Präsidium (8)
- Biochemie und Chemie (7)
- Biochemie, Chemie und Pharmazie (7)
- Biowissenschaften (7)
- Wirtschaftswissenschaften (7)
- Center for Financial Studies (CFS) (6)
Background: For rheumatoid arthritis (RA), the treat-to-target concept suggests attaining remission or at least low disease activity (LDA) after 12 weeks.
Objectives: This German, prospective, multicenter, non-interventional study aimed to determine the proportion of patients with RA who achieved their treat-to-target aim after 12 and 24 weeks of etanercept (ETN) treatment in a real-life setting, as opposed to patients achieving their therapeutic target at a later timepoint (week 36 or 52).
Methods: A total of 824 adults with a confirmed diagnosis of RA without prior ETN treatment were included. Remission and LDA were defined as DAS28 < 2.6 and DAS28 ≤ 3.2, respectively.
Results: The proportion of patients achieving remission was 24% at week 12 and 31% at week 24. The proportion of patients achieving LDA was 39% at week 12 and 45% at week 24. The proportion of patients achieving remission or LDA further increased beyond week 24 up to week 52. Improvement in pain and reduction in concomitant glucocorticoid treatment were observed. Improvements in patient-reported outcomes were also seen in patients who did not reach remission or LDA. No new safety signals were detected.
Conclusions: A considerable proportion of patients with RA attained the target of remission or LDA after 12 weeks of ETN treatment. Even beyond that timepoint, the proportion of patients achieving treatment targets continued to increase up to week 52.
Trial Registration
ClinicalTrials.gov Identifier: NCT02486302.
Plain Language Summary
Physicians measure response to treatment of rheumatoid arthritis using a disease activity score (DAS28). People with a DAS28 of less than 2.6 have very few to no symptoms (also called remission). People with a DAS28 of 3.2 or less, called low disease activity, may experience mild symptoms. When people do not respond to treatment after 12 weeks, it is usually recommended to prescribe a different treatment. Researchers do not know how many people who do not respond after 12 weeks would respond if treatment were continued. A total of 824 German people with rheumatoid arthritis who received a drug called etanercept for up to 52 weeks took part in this study. Researchers wanted to know how many people had remission or low disease activity after 12 weeks and 24 weeks of treatment.
After 12 weeks, 24 in 100 people had remission; this increased to 31 in 100 people after 24 weeks. Thirty-nine in 100 people had low disease activity after 12 weeks; this increased to 45 in 100 people after 24 weeks. The number of people with remission or low disease activity increased with longer treatment (up to 52 weeks). People needed less additional treatment with a type of drug called glucocorticoids. The people in this study experienced side effects that were similar to those reported by people who took etanercept in previous studies.
The researchers concluded that a considerable proportion of people responded to treatment with etanercept after 12 weeks. This proportion increased when treatment was continued for longer than 12 weeks.
Background: Despite advances in treatment of patients with non-small cell lung cancer, carriers of certain genetic alterations are prone to failure. One such factor frequently mutated, is the tumor suppressor PTEN. These tumors are supposed to be more resistant to radiation, chemo- and immunotherapy.
Results: We demonstrate that loss of PTEN led to altered expression of transcriptional programs which directly regulate therapy resistance, resulting in establishment of radiation resistance. While PTEN-deficient tumor cells were not dependent on DNA-PK for IR resistance nor activated ATR during IR, they showed a significant dependence for the DNA damage kinase ATM. Pharmacologic inhibition of ATM, via KU-60019 and AZD1390 at non-toxic doses, restored and even synergized with IR in PTEN-deficient human and murine NSCLC cells as well in a multicellular organotypic ex vivo tumor model.
Conclusion: PTEN tumors are addicted to ATM to detect and repair radiation induced DNA damage. This creates an exploitable bottleneck. At least in cellulo and ex vivo we show that low concentration of ATM inhibitor is able to synergise with IR to treat PTEN-deficient tumors in genetically well-defined IR resistant lung cancer models.